Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry

PURPOSE: Immediate and proper implementation of a new and more potent therapy is important to ensure that the patient achieves the best possible outcome. This study aimed to examine whether the real-world overall survival (OS) has improved in patients with human epidermal growth factor receptor 2-po...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer Res Treat
Hlavní autoři: Ibragimova, Khava I. E., Geurts, Sandra M. E., Croes, Sander, Erdkamp, Frans, Heijns, Joan B., Tol, Jolien, Vriens, Birgit E. P. J., Aaldering, Kirsten N. A., Dercksen, Marcus W., Pepels, Manon J. A. E., Peters, Natascha A. J. B., van de Winkel, Linda, Tilli, Dominique J. P., Vriens, Ingeborg J. H., de Boer, Maaike, Tjan-Heijnen, Vivianne C. G.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer US 2021
Témata:
Epidemiology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8260428/
https://ncbi.nlm.nih.gov/pubmed/33743103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-021-06178-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky